This invention relates to a novel group of 8-Alkyl/Aryl-4-aryl-2-N-(alkylamino)-N"- substituted-N'-cyanoguanidino-8H-pyrido[2,3-d]pyrimidin-7-one compounds, processes for the preparation thereof, the use thereof in treating CSBP/p38 kinase mediated diseases and pharmaceutical compositions for use in such therapy.
申请公布号
WO2006110298(A2)
申请公布日期
2006.10.19
申请号
WO2006US10908
申请日期
2006.03.24
申请人
GLAXO GROUP LIMITED;BOEHM, JEFFREY, C.;TAGGART, JOHN, J.